Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2044.00    -42.00 (-2.01%)
Bid:
2044.00
Ask:
2052.00
Spread: 8.00 (0.391%)
Market Cap: £3.43b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Result of AGM

17 Jul 2025 14:20

RNS Number : 5385R
Johnson Matthey PLC
17 July 2025
 

17th July 2025

 

Johnson Matthey Plc

(the Company)

Result of Annual General Meeting

 

 

The Company announces that at today's Annual General Meeting all resolutions were passed on a poll. The result of the poll is set out below.

Resolution

For

% For*

Against

% Against*

Votes Total

% of Issued Share Capital

Votes Withheld**

1. To receive the Company's accounts for the year ended 31st March 2025.

125,474,164

100.00

3,573

0.00

125,477,737

74.76

299,337

2. To approve the directors' remuneration report for the year ended 31st March 2025.

124,682,730

99.46

675,327

0.54

125,358,057

74.69

419,017

3. To declare a final dividend of 55.00 pence per ordinary share.

125,717,427

99.98

22,304

0.02

125,739,731

74.92

37,343

4. To elect Sinead Lynch as a director of the company.

125,634,299

99.94

79,717

0.06

125,714,016

74.90

63,058

5. To elect Richard Pike as a director of the company.

125,144,636

99.55

567,319

0.45

125,711,955

74.90

65,119

6. To re-elect Liam Condon as a director of the company.

125,664,213

99.96

51,658

0.04

125,715,871

74.90

61,203

7. To re-elect Rita Forst as a director of the company.

121,948,589

97.00

3,767,419

3.00

125,716,008

74.90

61,066

8. To re-elect Barbara Jeremiah as a director of the company.

121,941,913

97.00

3,771,603

3.00

125,713,516

74.90

63,558

9. To re-elect Xiaozhi Liu as a director of the company.

121,889,457

96.96

3,822,189

3.04

125,711,646

74.90

65,428

10. To re-elect John O'Higgins as a director of the company.

121,851,667

96.92

3,868,298

3.08

125,719,965

74.91

57,109

11. To re-elect Doug Webb as a director of the company.

121,893,706

96.96

3,817,302

3.04

125,711,008

74.90

66,066

12. To re-appoint PricewaterhouseCoopers LLP as auditor for the forthcoming year.

125,373,304

99.98

24,237

0.02

125,397,541

74.71

379,533

13. To authorise the Audit Committee to determine the remuneration of the auditor.

125,732,779

99.98

24,926

0.02

125,757,705

74.93

19,369

14. To authorise the company and its subsidiaries to make political donations and incur political expenditure within certain limits.

124,684,913

99.15

1,065,207

0.85

125,750,120

74.92

26,954

15. To authorise the directors to allot shares.

123,841,042

98.48

1,909,401

1.52

125,750,443

74.92

26,631

16. To renew the JM Share Incentive Plan

125,665,377

99.95

64,810

0.05

125,730,187

74.91

46,887

17. To disapply the statutory pre-emption rights attaching to shares.***

121,168,659

96.37

4,570,518

3.63

125,739,177

74.92

37,897

18. To disapply the statutory pre-emption rights attaching to shares in connection with an acquisition or other capital investment.***

119,467,352

95.01

6,276,618

4.99

125,743,970

74.92

33,104

19. To authorise the company to make market purchases of its own shares.***

123,298,268

98.12

2,357,219

1.88

125,655,487

74.87

121,587

20. To authorise the company to call general meetings other than annual general meetings on not less than 14 clear days' notice.***

123,336,160

98.07

2,422,257

1.93

125,758,417

74.93

18,657

 

* Figures shown are percentages of total votes cast excluding votes withheld

** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes for or against a resolution

*** Special Resolutions

The total number of voting rights was 167,838,789 Ordinary Shares of 11049/53 pence.

Copies of our announcements are available on our website: https://matthey.com/investors/regulatory-news

In accordance with UK Listing Rule 6.4.2, a copy of all resolutions passed as special business will shortly be available for inspection at the National Storage Mechanism document viewing facility at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

ENDS

 

 

Enquiries: 

Investor Relations

Martin Dunwoodie

Louise Curran

Director of Investor Relations

Senior Investor Relations Manage

+44 20 7269 8241

+44 20 7269 8235

Media

Sinead Keller

Group Corporate Affairs Director

+44 20 7269 8218

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered Office: 5th Floor, 2 Gresham Street, London EC2V 7AD

Registered in England & Wales number: 00033774 Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

ISIN number: GB00BZ4BQC70

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPKOBDNBKDFOD
Date   Source Headline
11th Jun 202612:17 pmRNSDirector/PDMR Shareholding
10th Jun 202610:00 amRNSAnnual Financial Report
3rd Jun 20269:03 amRNSDirector/PDMR Shareholding
2nd Jun 20264:40 pmRNSDirector/PDMR Shareholding
1st Jun 20264:02 pmRNSHolding(s) in Company
28th May 20267:05 amRNSBoard Changes
28th May 20267:01 amRNSJohnson Matthey acquisition of Cormetech
28th May 20267:00 amRNSJohnson Matthey Full Year Results
14th May 202611:42 amRNSDirector/PDMR Shareholding
16th Apr 202611:51 amRNSDirector/PDMR Shareholding
24th Mar 202611:30 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSDirector Declaration
24th Feb 20263:30 pmRNSDirector/PDMR Shareholding
24th Feb 20269:48 amRNSDirector/PDMR Shareholding
23rd Feb 20265:19 pmRNSDirector/PDMR Shareholding
23rd Feb 20267:00 amRNSUpdate on Catalyst Technologies sale
12th Feb 202612:44 pmRNSDirector/PDMR Shareholding
14th Jan 20262:22 pmRNSDirector/PDMR Shareholding
8th Jan 202610:01 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
11th Dec 20254:51 pmRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSDirectorate change
20th Nov 20257:00 amRNSJohnson Matthey Half Year Results
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
24th Oct 202511:29 amRNSHolding(s) in Company
21st Oct 20253:44 pmRNSHolding(s) in Company
13th Oct 202511:55 amRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSFinancial reporting structure and trading update
3rd Oct 202510:23 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSHolding(s) in Company
26th Sep 20255:29 pmRNSHolding(s) in Company
17th Sep 20259:00 amRNSDirector Declaration
15th Sep 20252:37 pmRNSHolding(s) in Company
11th Sep 20254:13 pmRNSDirector/PDMR Shareholding
8th Sep 20256:00 pmRNSHolding(s) in Company
4th Sep 20255:19 pmRNSHolding(s) in Company
2nd Sep 20254:07 pmRNSHolding(s) in Company
29th Aug 202512:05 pmRNSTotal Voting Rights
26th Aug 20252:07 pmRNSDirector/PDMR Shareholding
13th Aug 20254:38 pmRNSDirector/PDMR Shareholding
13th Aug 20251:51 pmRNSDirector/PDMR Shareholding
5th Aug 20255:19 pmRNSHolding(s) in Company
5th Aug 20254:50 pmRNSDirector/PDMR Shareholding
25th Jul 20252:12 pmRNSHolding(s) in Company
23rd Jul 20252:23 pmRNSHolding(s) in Company
18th Jul 202512:07 pmRNSDirector/PDMR Shareholding
18th Jul 20259:18 amRNSHolding(s) in Company
17th Jul 20252:20 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.